Dar Al Dawa Development and Investment Company PSC operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dar Al Dawa Development and Investment Company PSC with three other
pharmaceutical manufacturers in Middle East:
El Nile Company for Pharmaceuticals and Chemical Industries SAE
sales of 812.54 million Egyptian Pounds [US$51.86 million]
Alexandria Company for Pharmaceuticals and Chemical Industries SAE
(1.02 billion Egyptian Pounds [US$65.40 million]
Kahira Pharmaceuticals and Chemical Industries Co
based in EGYPT
(1.01 billion Egyptian Pounds [US$64.49 million]
During the first
quarter of 2021, sales at Dar Al Dawa Development and Investment Company PSC totalled
11.21 million Jordanian Dinars.
an increase of 2.2%
from the 10.97 million Jordanian Dinars in sales at the company during the first quarter of 2020.
There appears to be at least some degree of seasonality in the sales at Dar Al Dawa Development and Investment Company PSC: during 8 of the previous 9
years, sales were highest during the fourth quarter.
The exception to this was during 2019, when the
third quarter was the best quarter, accounting for
33% of sales (during that same year, the
fourth quarter accounted for 29% of sales).
Dar Al Dawa Development and Investment Company PSC reported sales of 53.15 million Jordanian Dinars (US$74.97 million)
December of 2020.
decrease of 3.1%
versus 2019, when the company's sales were 54.86 million Jordanian Dinars.
Contributing to the drop in overall sales was the 10.6% decline
in Babies Cereals and Formula Milk, from 13.85 million Jordanian Dinars to 12.38 million Jordanian Dinars.
There were also decreases in sales in
Medicine (down 0.6% to 40.77 million Jordanian Dinars)